ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles
Open accessAbstract
Background & Aims Excessive alcohol consumption is one of the major causes of hepatocellular carcinoma (HCC). Approximately 30–40% of the Asian population are deficient for aldehyde dehydrogenase 2 (ALDH2), a key enzyme that detoxifies the ethanol metabolite acetaldehyde. However, how ALDH2 deficiency affects alcohol-related HCC remains unclear. Methods ALDH2 polymorphisms were studied in 646 patients with viral hepatitis B (HBV) infection, who did or did not drink alcohol. A new model of HCC induced by chronic carbon tetrachloride (CCl 4 ) and alcohol administration was developed and studied in 3 lines of Aldh2 -deficient mice: including Aldh2 global knockout (KO) mice, Aldh2*1/*2 knock-in mutant mice, and liver-specific Aldh2 KO mice. Results We demonstrated that ALDH2 deficiency was not associated with liver disease progression but was associated with an increased risk of HCC development in cirrhotic patients with HBV who consumed excessive alcohol. The mechanisms underlying HCC development associated with cirrhosis and alcohol consumption were studied in Aldh2 -deficient mice. We found that all 3 lines of Aldh2 -deficient mice were more susceptible to CCl 4 plus alcohol-associated liver fibrosis and HCC development. Furthermore, our results from in vivo and in vitro mechanistic studies revealed that after CCl 4 plus ethanol exposure, Aldh2 -deficient hepatocytes produced a large amount of harmful oxidized mitochondrial DNA via extracellular vesicles, which were then transferred into neighboring HCC cells and together with acetaldehyde activated multiple oncogenic pathways (JNK, STAT3, BCL-2, and TAZ), thereby promoting HCC. Conclusions ALDH2 deficiency is associated with an increased risk of alcohol-related HCC development from fibrosis in patients and in mice. Mechanistic studies reveal a novel mechanism that Aldh2 -deficient hepatocytes promote alcohol-associated HCC by transferring harmful oxidized mitochondrial DNA-enriched extracellular vesicles into HCC and subsequently activating multiple oncogenic pathways in HCC. Lay summary Alcoholics with an ALDH2 polymorphism have an increased risk of digestive tract cancer development, however, the link between ALDH2 deficiency and hepatocellular carcinoma (HCC) development has not been well established. In this study, we show that ALDH2 deficiency exacerbates alcohol-associated HCC development both in patients and mouse models. Mechanistic studies revealed that after chronic alcohol exposure, Aldh2 -deficient hepatocytes produce a large amount of harmful oxidized mitochondrial DNA via extracellular vesicles, which can be delivered into neighboring HCC cells and subsequently activate multiple oncogenic pathways, promoting HCC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ALDH2-KO mice are more sensitive to ethanol-induced liver inflammation, fibrosis, and HCC, except hepatic steatosis, than wild-type mice.
“In addition, ALDH2-KO mice have been shown to be more sensitive to ethanol-induced liver inflammation, fibrosis, and HCC, except hepatic steatosis, than wild-type mice [82,121].”
From Pathophysiological Aspects of Alcohol Metabolism in the Liver (2021) · cites this paper as [121]
The Results section ('Aldh2-deficient mice are more susceptible to CCl4+EtOH-induced HCC'; page unavailable) reports greater fibrosis and more and larger tumors in Aldh2-knockout mice than in wild-type mice after combined CCl4 and ethanol treatment. It describes inflammation and steatosis in treated mice but does not establish that inflammation was greater in knockouts or that steatosis was unchanged between genotypes. The claim also omits the CCl4 treatment required for the reported fibrosis and HCC comparison. (LLM, conf=0.88)
Experimental — accuracy not yet measuredALDH2 is a key enzyme that detoxifies acetaldehyde and is highly expressed in liver, heart, and brain.
“Aldehyde dehydrogenase 2 (ALDH2), a key enzyme that detoxifies the ethanol metabolite acetaldehyde, is highly expressed in the liver, heart, and brain [[174], [175], [176]].”
From Emerging role of liver-bone axis in osteoporosis (2024) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 35 · Cited by 218
- Authors
- Seo, W., Gao, Y., He, Y., Sun, J., Xu, H., Feng, D., Park, S. H., Cho, Y.-E., Guillot, A., Ren, T., Wu, R., Wang, J., Kim, S.-J., Hwang, S., Liangpunsakul, S., Yang, Y., Niu, J., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Jilin University (CN)
- Richard L. Roudebush VA Medical Center (US)
- Harvard University (US)
- Corresponding author
- Gao, Bin
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 71
- Issue
- 5
- Pages
- 1000-1011
- ISSN
- 0168-8278 (ISSN-L)
- PMC
- PMC6801025
- OpenAlex
- W2954123950
- Cited by
- 218
- References
- 35
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 32 · 2023: 38 · 2022: 37 · 2021: 16 · 2020: 21 · 2019: 7
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- ALDH2 deficiency, hepatocellular carcinoma, oxidized mitochondrial DNA, extracellular vesicles, acetaldehyde, liver cirrhosis, hepatitis B, carbon tetrachloride, JNK signaling, STAT3, Bcl-2, TAZ, oncogenic signaling, liver fibrosis
- MeSH terms
- Extracellular Vesicles, Aldehyde Dehydrogenase, Mitochondrial, Adult, Alcohol Drinking, Alcoholism, Animals, Carbon Tetrachloride, Disease Models, Animal, DNA, Mitochondrial, Female, Hepatitis B virus, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Cohort Studies, Mice, Knockout, Hepatitis B, Chronic, Hepatocytes, Mice, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review